Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

+24.02%
3Y annualised
+1.33% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 15 Apr '26
₹34.26
Min. for SIP
₹100
Fund size (AUM)
₹858.87 Cr
Expense ratio
1.02%
Rating
2

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
6 months₹30,000₹30,308
+1.03%
1 year₹60,000₹61,022
+1.70%
3 years₹1,80,000₹2,14,558
+19.20%
5 years₹3,00,000₹4,32,836
+44.28%

Holdings (37)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity13.42%
Apollo Hospitals Enterprise Ltd.HealthcareEquity7.34%
Torrent Pharmaceuticals Ltd.HealthcareEquity5.03%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity4.99%
Aurobindo Pharma Ltd.HealthcareEquity4.42%
Ajanta Pharma Ltd.HealthcareEquity4.22%
Lupin Ltd.HealthcareEquity4.21%
Ipca Laboratories Ltd.HealthcareEquity4.11%
Abbott India Ltd.HealthcareEquity3.90%
Fortis Healthcare Ltd.HealthcareEquity3.49%
Emcure Pharmaceuticals Ltd.HealthcareEquity3.30%
Cipla Ltd.HealthcareEquity3.24%
Mankind Pharma Ltd.HealthcareEquity2.93%
Shilpa Medicare Ltd.HealthcareEquity2.26%
Alkem Laboratories Ltd.HealthcareEquity2.16%
CORONA Remedies Ltd.HealthcareEquity2.12%
Sai Life Sciences Ltd.HealthcareEquity2.09%
Procter & Gamble Health Ltd.HealthcareEquity1.97%
Jupiter Life Line Hospitals Ltd.HealthcareEquity1.96%
Divi's Laboratories Ltd.HealthcareEquity1.80%
Sanofi Consumer Healthcare India Ltd.HealthcareEquity1.58%
Dr. Reddy's Laboratories Ltd.HealthcareEquity1.45%
Thyrocare Technologies Ltd.HealthcareEquity1.44%
Pfizer Ltd.HealthcareEquity1.40%
Metropolis Healthcare Ltd.HealthcareEquity1.36%
Alembic Pharmaceuticals Ltd.HealthcareEquity1.24%
Biocon Ltd.HealthcareEquity1.14%
Jubilant Pharmova Ltd.HealthcareEquity1.11%
Anthem Biosciences Ltd.HealthcareEquity1.08%
Gland Pharma Ltd.HealthcareEquity0.99%
Piramal Pharma Ltd.HealthcareEquity0.92%
Medi Assist Healthcare Services Ltd.ServicesEquity0.90%
Suraksha Diagnostic Ltd.HealthcareEquity0.89%
Glaxosmithkline Pharmaceuticals Ltd.HealthcareEquity0.87%
Vijaya Diagnostic Centre Ltd.HealthcareEquity0.78%
Max Healthcare Institute Ltd.HealthcareEquity0.78%
Vinati Organics Ltd.ChemicalsEquity0.73%
See All

Minimum investments

Min. for 1st investment
₹1,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+7.4%+24.0%+14.4%+19.9%
Category average (Equity Sectoral)-2.1%+22.1%+14.6%--
Rank (Equity Sectoral)958--

Exit load, stamp duty and tax

Exit load

Exit load of 1% if redeemed within 30 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Check past data

Fund management

DS
Dhaval Shah
Jun 2019 - Present
View details

Education
Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.
Experience
Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.

About Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 23 Dec 1994. Dhaval Shah is the Current Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹3,86,321 Cr and the Latest NAV as of 15 Apr 2026 is ₹34.26. The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹1,000. Exit load of 1% if redeemed within 30 days. ;

Investment Objective

The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#4 in India
Total AUM₹3,86,320.68 Cr
Date of Incorporation23 Dec 1994
Launch Date23 Dec 1994
AddressOne World Center, Tower 1, 17th Floor, Jupiter Mill CompoundSenapati Bapat Marg, Elphinstone Road Mumbai 400013
CustodianCitibank NA
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,